Search Page

1

Cite

Share

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.

Illa I, Diaz-Manera J, Rojas-Garcia R, Pradas J, Rey A, Blesa R, Juarez C, Gallardo E. Illa I, et al. Among authors: juarez c. J Neuroimmunol. 2008 Sep 15;201-202:90-4. doi: 10.1016/j.jneuroim.2008.04.039. Epub 2008 Jul 23. J Neuroimmunol. 2008. PMID: 18653247

Cite

Share

2

Cite

Share

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.

Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC. Illa I, et al. Among authors: juarez c. Ann Neurol. 1995 Aug;38(2):218-24. doi: 10.1002/ana.410380214. Ann Neurol. 1995. PMID: 7654069

Cite

Share

3

Cite

Share

Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab.

Rojas-García R, Gallardo E, de Andrés I, de Luna N, Juarez C, Sánchez P, Illa I. Rojas-García R, et al. Among authors: juarez c. Neurology. 2003 Dec 23;61(12):1814-6. doi: 10.1212/01.wnl.0000098996.02934.86. Neurology. 2003. PMID: 14694058

Cite

Share

4

Cite

Share

Cutaneous ulcers with type I cryoglobulinemia treated with plasmapheresis.

Vila AT, Barnadas MA, Ballarin J, Garcia R, Juarez C, Madoz P, Ramila E, Alomar A. Vila AT, et al. Among authors: juarez c. Eur J Dermatol. 2004 May-Jun;14(3):186-9. Eur J Dermatol. 2004. PMID: 15246947

Cite

Share

5

Cite

Share

["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].

Illa I, Díaz-Manera JA, Juárez C, Rojas-García R, Molina-Porcel L, Aleu A, Pradas J, Gallardo E. Illa I, et al. Among authors: juarez c. Med Clin (Barc). 2005 Jun 18;125(3):100-2. doi: 10.1157/13076937. Med Clin (Barc). 2005. PMID: 15989843 Spanish.

Cite

Share

6

Cite

Share

A novel antiganglioside specificity against terminal NeuNAc(alfa 2-3)Gal in acute bulbar palsy.

Rojas-Garcia R, Martinez-Lage M, Gallardo E, de Luna N, Marti-Vilalta JL, Diaz-Manera J, Juarez C, Blesa R, Illa I. Rojas-Garcia R, et al. Among authors: juarez c. J Neuroimmunol. 2006 Jul;176(1-2):219-22. doi: 10.1016/j.jneuroim.2006.04.001. Epub 2006 May 16. J Neuroimmunol. 2006. PMID: 16707165

Cite

Share

7

Cite

Share

Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.

Díaz-Manera J, Rojas-García R, Gallardo E, Juárez C, Martínez-Domeño A, Martínez-Ramírez S, Dalmau J, Blesa R, Illa I. Díaz-Manera J, et al. Among authors: juarez c. Nat Clin Pract Neurol. 2007 Jul;3(7):405-10. doi: 10.1038/ncpneuro0526. Nat Clin Pract Neurol. 2007. PMID: 17611489

Cite

Share

8

Cite

Share

Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal.

Rojas-Garcia R, Gallardo E, De Luna N, Juarez C, Martinez-Hernandez E, Carvajal A, Casasnovas C, Fages E, Davila-González P, Illa I. Rojas-Garcia R, et al. Among authors: juarez c. J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):623-8. doi: 10.1136/jnnp.2009.183517. Epub 2009 Sep 2. J Neurol Neurosurg Psychiatry. 2010. PMID: 19726412

Cite

Share

9

Cite

Share

Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression.

Moga E, Cantó E, Vidal S, Juarez C, Sierra J, Briones J. Moga E, et al. Among authors: juarez c. Exp Hematol. 2011 Nov;39(11):1064-71. doi: 10.1016/j.exphem.2011.08.006. Epub 2011 Aug 22. Exp Hematol. 2011. PMID: 21864486 Free article.

Cite

Share

10

Cite

Share

Long-lasting treatment effect of rituximab in MuSK myasthenia.

Díaz-Manera J, Martínez-Hernández E, Querol L, Klooster R, Rojas-García R, Suárez-Calvet X, Muñoz-Blanco JL, Mazia C, Straasheijm KR, Gallardo E, Juárez C, Verschuuren JJ, Illa I. Díaz-Manera J, et al. Among authors: juarez c. Neurology. 2012 Jan 17;78(3):189-93. doi: 10.1212/WNL.0b013e3182407982. Epub 2012 Jan 4. Neurology. 2012. PMID: 22218276 Clinical Trial.

Cite

Share